Adjuvant Dual Anti-HER2 Therapy in Patients With Small, Node-negative, HER2-positive Breast Cancer
Condition: HER2-positive Breast Cancer Interventions: Drug: Pyrotinib; Drug: Trastuzumab Sponsor: xuexin he Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials